Biotech peptides exploration is reshaping how medicines are made—shifting from wide-spectrum drugs towards highly unique molecules that may be tuned for potency, selectivity, and patient compatibility. In my watch, the most enjoyable shift is not really basically that peptides are “superior,” but that the whole discovery pipeline—synthesis,